Cetera Investment Advisers
DFTX

Cetera Investment Advisers’s Definium Therapeutics DFTX Stock Holding History

Cetera Investment Advisers’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Sell
14,029
-17,795
-56% -$440K ﹤0.01% 3434
2026
Q1 		$601K Buy
31,824
+15,224
+92% +$258K ﹤0.01% 3338
2025
Q4 		$222K Buy
16,600
+358
+2% +$4.43K ﹤0.01% 4167
2025
Q3 		$191K Buy
+16,242
New +$151K ﹤0.01% 4164

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cetera Investment Advisers's DFTX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Definium Therapeutics (DFTX) stake by 56% in Q2 2026, selling an estimated $440K and leaving 14,029 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

Cetera Investment Advisers first reported a position in DFTX in Q3 2025 and has held it in 4 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Cetera Investment Advisers held 14,029 shares of Definium Therapeutics worth $660K as of Q2 2026.
  • Cetera Investment Advisers sold 17,795 Definium Therapeutics shares in Q2 2026, an estimated $440K.
  • Definium Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3434 holding.
  • Cetera Investment Advisers first reported a position in Definium Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.